- Medical tech support company Opyl (OPL) has received commitments for a share placement to raise approximately $1.38 million
- Opyl, through the placement, will issue 9.2 million fully paid ordinary shares at 15 cents each
- This price represents a 16.7 per cent discount to the last closing price on March 26, and an 18.1 per cent discount to the 15-day volume-weighted average price
- Additionally, the company is set to introduce a share purchase plan (SPP) to all eligible shareholders, open from March 31 to April 16
- The SPP will allow shareholders to subscribe for up to $30,000 in fully paid ordinary shares to raise an estimated $200,000
- OPL will use funds generated via the placement and SPP to accelerate the company’s growth
- Opyl shares have dropped 8.3 per cent, trading at 16.5 cents each
Medical tech support company Opyl (OPL) has received commitments for a share placement to raise approximately $1.38 million before costs.
Based in Melbourne, Opyl provides biopharma and health organisations access to emerging automated intelligence-assisted technologies and data insights to improve healthcare design, development, and delivery.
Opyl, through the oversubscribed share placement, is set to issue 9.2 million fully paid ordinary shares at 15 cents each.
This price represents a 16.7 per cent discount to the last closing price on March 26, and an 18.1 per cent discount to the 15-day volume-weighted average price.
Further, the company is will also introduce a share purchase plan (SPP) to all eligible shareholders, open from March 31 to April 16.
Through the plan, shareholders will have the opportunity to subscribe for up to $30,000 of fully paid ordinary shares in a non-underwritten SPP to raise an estimated $200,000.
Shares under the SPP will be offered at a fixed price of 15 cents each and subject to the same terms as the above placement.
Opyl will use the funds raised through the placement and SPP to accelerate the company’s growth.
Proceeds will go towards completing the buyback of small, unmarketable shares announced earlier this month as well as expanding its digital offering, strengthening its sales team and adding to working capital.
Opyl shares have dropped 8.33 per cent and are trading at 16.5 cents each at 3:31 pm AEDT.